Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 1, Issue 19, Pages 3304-3315Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b304945k
Keywords
-
Categories
Funding
- NCRR NIH HHS [1 S10 RR10444, RR 07141, RR 04648, RR 11966] Funding Source: Medline
- NIGMS NIH HHS [GM58822, GM 27029] Funding Source: Medline
- NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010444, S10RR004648, S10RR011966] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058822, R01GM027029] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Selenocysteine derivatives are useful precursors for the synthesis of peptide conjugates and selenopeptides. Several diastereomers of Fmoc-3-methyl-Se-phenylselenocysteine (FmocMeSec(Ph)) were prepared and used in solid phase peptide synthesis ( SPPS). Once incorporated into peptides, the phenylselenide functionality provides a useful handle for the site and stereospecific introduction of E- or Z-dehydrobutyrine residues into peptide chains via oxidative elimination. The oxidation conditions are mild, can be performed on a solid support, and tolerate functionalities commonly found in peptides, including variously protected cysteine residues. Dehydropeptides containing unprotected cysteine residues undergo intramolecular stereoselective conjugate addition to afford cyclic lanthionines and methyllanthionines, which have the same stereochemistry as found in lantibiotics, a family of ribosomally synthesized and post-translationally modified peptide antibiotics. The observed stereoselectivity is shown to originate from a kinetic rather than a thermodynamic preference.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available